RSNA 2009 

Abstract Archives of the RSNA, 2009


SSQ15-09

Comparison of Prognostic Capability among I-131 Whole Body Scintigraphy, FDG-PET/CT, Tc-99m-MIBI Scintigraphy, and Diffusion-weighted MR in Postoperative Thyroid Cancer

Scientific Papers

Presented on December 3, 2009
Presented as part of SSQ15: ISP:  Nuclear Medicine (Endocrine and Neuroendocrine Imaging)

Participants

Shigeki Nagamachi MD, PhD, Presenter: Nothing to Disclose
Hideyuki Wakamatsu MD, Abstract Co-Author: Nothing to Disclose
Syogo Kiyohara, Abstract Co-Author: Nothing to Disclose
Seigo Fujita MD, Abstract Co-Author: Nothing to Disclose
Kiyohisa Kamimura MD, Abstract Co-Author: Nothing to Disclose
Shigemi Futami, Abstract Co-Author: Nothing to Disclose
Ryuichi Nishii MD, PhD, Abstract Co-Author: Nothing to Disclose
Shozo Tamura MD, PhD, Abstract Co-Author: Nothing to Disclose
00030490-DMT et al, Abstract Co-Author: Nothing to Disclose

PURPOSE

The aim of this study was to evaluate the clinical significance of FDG PET/CT in predicting prognosis of differentiated thyroid cancer (DTC) and to compare the results with those obtained from chest and neck DWI or Tc-99m MIBI scintigraphy.

METHOD AND MATERIALS

In 65 patients (22 men, 43 women; 27-71yr; mean age, 55.3y) with differentiated thyroid cancer (DTC) after total thyroidectomy, whole-body FDG PET/CT, Tc-99m-MIBI scintigraphy and chest and neck diffusion weighted MRI (DWI) was performed before I-131 therapy. We defined as ‘The poor prognoses by referencing either (1) or (2) condition. (1)The value of serum thyroglobulin (Tg) re-increased during follow up periods after I-131 therapy (2) The tumor volume or number of lesion’s increased during follow up periods. Patients without above the both conditions were defined as ‘The good prognoses. Mean follow up periods after 131I-therapy was 3.1±0.8 years. We compared the possible influencing factors, age, gender, Tg level, therapy number, histological differentiation, stage of the disease, between the two groups.

RESULTS

In the correlation analysis with prognostic capability, gender (male), age (>45) and histological differentiation (poor) were also significant determinant for the poor prognoses. In addition, FDG positivity, Tc-99m-MIBI positivity and DWI high signal intensity were statistically significant prognostic determinant for the poor prognoses respectively.

CONCLUSION

In the prediction of DTC’s prognosis, either FDG positivity or Tc-99m-MIBI positivity or existence of DWI high signal intensity lesions tended to be poor prognosis. Because DWI provides similar information with FDG PET/CT, the combination of IWBS and DWI will be the alternative method for monitoring after I-131 therapy and for predicting prognosis.

CLINICAL RELEVANCE/APPLICATION

Because FDG PET/CT, Tc-99m-MIBI and DWI provide similar information regarding prognosis in DTC, we may choose relevant modality in accordance with the institute circumstance.  

Cite This Abstract

Nagamachi, S, Wakamatsu, H, Kiyohara, S, Fujita, S, Kamimura, K, Futami, S, Nishii, R, Tamura, S, et al, 0, Comparison of Prognostic Capability among I-131 Whole Body Scintigraphy, FDG-PET/CT, Tc-99m-MIBI Scintigraphy, and Diffusion-weighted MR in Postoperative Thyroid Cancer.  Radiological Society of North America 2009 Scientific Assembly and Annual Meeting, November 29 - December 4, 2009 ,Chicago IL. http://archive.rsna.org/2009/8011185.html